Using AI assessment to tackle dementia in ultra-early stages (Digital Health):
“Dementia and Alzheimer’s disease continue to increase and remain the leading cause of death in England and Wales, accounting for 12.8% of all deaths registered in 2018 … While there is no cure available, catching diseases like Alzheimer’s early on can help those living with the condition to slow its progression.
Cognetivity Neurosciences, a Cambridge University spin-out based in London, has developed an artificial-intelligence (AI) powered test designed to detect cognitive decline in its ultra-early stages – potentially detecting dementia and related conditions up to 15 years before a formal diagnosis.
The five-minute iPad test, which is currently undergoing clinical validation trials at eight NHS trusts, is designed to be administered as part of a patient’s annual health check-up, much as a GP would perform a blood pressure test … The test, which is underpinned by a proprietary machine learning system, scores each patient’s speed, accuracy and attention using a traffic light system, which can then be used by a healthcare professional to aid diagnosis.
Scoring in the red zone would indicate cognitive issues where a referral to a memory clinic would be recommended.”
News in Context:
- Brainnovations Winner Jan Samzelius on why monitoring Typing Cadence may help detect early Parkinson’s and Alzheimer’s Disease
- Study: 46.7 million Americans have Alzheimer’s Disease brain pathology today, so it’s urgent to prevent or at least delay progression to clinical disease
- Bill Gates announces $50 million investment to fight Alzheimer’s Disease
- Solving the Brain Fitness Puzzle Is the Key to Self-Empowered Aging
- Report: 35% of worldwide dementia cases could be prevented by modifying these 9 modifiable risk factors